CMRO is proud to be the host of the National Association of Specialty Pharmacy's Annual Meeting & Expo 2023 Abstracts for the third time! Read here: 👉👉👉👉https://t.co/67A6498J7w
🚨 New special issue now online 🚨
Read our latest special issue, which delves further into the different aspects surrounding #Vasculitis. The issue is freely available for everyone to read until next month.
Click here to read the full articles now ➡️ https://t.co/cuNRgs7SS1
Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease.
Findings, published by @UNSWMedicine researchers in @CMRO_Journal, show it is an important CHD predictor in people 60+⚠️
https://t.co/VEtJdEtW2b
ISPOR 2023, the leading global conference for health economics and outcomes research (#HEOR), May 7-10 at the Boston Convention & Exhibition Center, Boston, MA, USA. Hear the latest hot topics and trends in #HEOR. #ISPORAnnual
click the link for more 👉https://t.co/mCrgrlMmfD
We are excited to share this recent supplement with everyone, which highlights the abstracts from the 17th Annual Cardiometabolic Health Congress (@CMHC_CME).
Click here to read the full supplement online ➡️ https://t.co/iQmvAzScnI #Cardiometabolic#Cardiovascular#Diabetes
Delighted to share a recent supplement, which has been published in Postgraduate Medicine, on "#Semaglutide for #weight management – an introduction for primary care."
Click here to read the full supplement ➡️ https://t.co/dIGxwbnpyK #WeightManagement#Obesity#PrimaryCare
Take a look at this new Editorial recently published in Hospital Practice, entitled "#Monkeypox virus-induced upregulation of interleukin-10 signaling: could #epigenetics be involved in long-term viral persistence?"
View the article now: https://t.co/fd85hE7xc6
Nearly 700,000 hospitalizations and 110,000 deaths prevented by the #Pfizervaccine in the US. Read the full article and press release by clicking the links below:
Press release: https://t.co/ltvnAzDrr7
Article: https://t.co/yNBnrMDQJX
#COVID#COVIDVACCINE
JME is delighted to release a foreword that celebrates the content it received in 2021. Including the top 5 cited articles and sections from the Editor in Chief and his deputy about their favorite articles from the last year.
Click the link for access👉https://t.co/jolNWJMsiZ
To start we would love to know what field you work in to establish who is benefiting most from the 2022 CHEERS statement. Please select one of the options or leave a comment below. #JMECHEERS2022
View the statement here 👉 https://t.co/s5BHuFrjKx
JME has co-published the CHEERS 2022 statement and is hosting a live twitter chat to find out what you think of the new guidelines. Click the link below to access the full statement and feel free to join the discussion. #JMECHEERS2022
View it here 👉 https://t.co/s5BHuFrjKx
Read this excellent editorial by Richard Smith, Chair of Patients Know Best and former Editor in Chief of @bmj_latest about the newly published @_OpenPharma Recommendations for #PlainLanguageSummaries https://t.co/Tb7bzYBsHH
Don't miss this newly published article from @_OpenPharma that provides recommendations for #PlainLanguageSummaries of peer-reviewed medical research articles | https://t.co/bQ2fIBsgTg
Our latest research article provides an important insight into the seroprevalence of #HepatitisB, #HepatitisC and Human Immunodeficiency Virus (#HIV).
Click the link for the abstract and details on how to access: https://t.co/0VWOr3zeME
Read our latest research article titled 'Results of preoperative screening for #COVID19 correlate with the incidence of infection in the general population -a tertiary care experience'. #coronavirus
click the link for the full article --> https://t.co/8uiafNGyvR
Read our latest review that looks at the increasing evidence that #COVID19 can effect the #centralnervoussystem
Click the link for access to the full article --> https://t.co/plw9Qa4g9l